EMEM Fibroblast
Modified EMEM for improved growth of fibroblasts · Cell-specific medium · RUO (P04-08049)
EMEM Fibroblasts is based on MEM Eagle (Minimum Essential Medium) which was in turn developed from BME (Basal Medium Eagle) suited for the propagation of a wide variety of cell lines. EMEM Fibroblasts was optimized to specifically suit the needs for cultivating fibroblasts. It is based on EMEM, supplemented with additional amino acids and vitamins and optimized for the growth of fibroblasts.
PAN-Biotech quality. EMEM Fibroblast is manufactured by PAN-Biotech / PAN-Celltech and released against a defined quality-control panel. A GMP grade is available on request.
Why
- Fibroblast-optimised – a modified EMEM formulation tuned for fibroblast and BHK21 growth.
- Reliable substrate – supports consistent cell expansion for virus propagation.
- Catalogue availability – stocked catalogue medium with short delivery times.
- Research to GMP – RUO catalogue product with a GMP grade available on request.
Specification
| Base | Modified EMEM for improved growth of fibroblasts |
| Format | Liquid (500 ml) |
| Storage | 2-8 °C |
| Stability | 2 years |
| Grade | RUO |
Ordering
| Grade | Art. No. | Pack size |
|---|---|---|
| RUO | P04-08049 | 500 ml |
Other pack sizes are available on request.
In the process – by application (upstream & downstream)
EMEM Fibroblast is used at the following process steps across the biologics platforms it supports:
Vaccines
- Cell-line-specific viral culture media – BHK21 / fibroblast viral vaccine substrates.
Frequently asked questions
What is EMEM Fibroblast optimised for?
It is a modified EMEM for improved growth of fibroblasts, including BHK21 cells.
In which grade is EMEM Fibroblast available?
It is available as a RUO product (P04-08049); a matching GMP grade is available on request.
One partner across every application. PAN-Biotech products support vaccine production, cell & gene therapy, monoclonal antibodies and mRNA – explore the full catalogue or use the Smart Product Search.
Related: Vaccine Production · Cell-Specific Media